BCPC:NSD-Balchem Corporation (USD)

COMMON STOCK | Specialty Chemicals |

Last Closing

USD 176.63

Change

-6.78 (-3.70)%

Market Cap

USD 5.96B

Volume

0.49M

Analyst Target

USD 115.33
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. Address: 5 Paragon Drive, Montvale, NJ, United States, 07645

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

+2.84 (+0.61%)

USD 227.97B
WDFC WD-40 Company

-6.10 (-2.20%)

USD 3.55B
IOSP Innospec Inc

-4.90 (-3.92%)

USD 2.70B
HWKN Hawkins Inc

+1.37 (+1.14%)

USD 2.45B
GEVO Gevo Inc

+0.18 (+10.47%)

USD 0.65B
LWLG Lightwave Logic Inc

-0.08 (-2.21%)

USD 0.42B
HDSN Hudson Technologies Inc

-0.05 (-0.85%)

USD 0.37B
ALTO Alto Ingredients Inc

-0.73 (-37.63%)

USD 0.15B
NTIC Northern Technologies

-0.35 (-2.53%)

USD 0.12B
LOOP Loop Industries Inc

+0.08 (+6.35%)

USD 0.06B

ETFs Containing BCPC

PSCM Invesco S&P SmallCap Mate.. 7.63 % 0.29 %

-1.52 (-1.14%)

USD 0.02B
KCAL 5.77 % 0.00 %

N/A

N/A
VEGB:LSE VanEck Sustainable Future.. 4.94 % 0.00 %

-0.28 (-1.14%)

N/A
VE6I:XETRA VanEck Sustainable Future.. 4.51 % 0.00 %

-0.24 (-1.14%)

N/A
IEAT:AU BetaShares Future of Food.. 0.00 % 0.00 %

-0.13 (-1.14%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -95.31% 5% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -95.31% 5% F 1% F
Trailing 12 Months  
Capital Gain -94.06% 6% D- 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -94.06% 6% D- 1% F
Trailing 5 Years  
Capital Gain -93.25% 9% A- 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -93.25% 9% A- 3% F
Average Annual (5 Year Horizon)  
Capital Gain 9.79% 47% F 62% D
Dividend Return 10.38% 41% F 60% D-
Total Return 0.58% 17% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 26.94% 88% B+ 67% D+
Risk Adjusted Return 38.52% 65% D 69% C-
Market Capitalization 5.96B 94% A 90% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.